The drug Wegovy, which is the brand name for semaglutide, is the first weight-loss medication to be approved in the UK as a preventative method for 'established cardiovascular disease'.
A weight-loss jab has been approved by the UK's medicines regulator for use in preventing heart attacks and strokes in overweight or obese adults. Wegovy, which is the brand name for the drug semaglutide, had already got the green light for weight management in those with obesity. The Medicines and Healthcare products Regulatory Agency has now allowed it to be used in helping overweight or obese people cut their risk of heart problems.
Heart attack or stroke risk cut by a fifth - study The approval comes as a new trial, involving 17,600 people, found that taking it as an injection once a week, for up to five years, can lower a person's risk of a major cardiovascular event - such as a heart attack or stroke - by 20%. While the National Institute for Health and Care Excellence is still to approve the treatment's use, Professor Sir Stephen Powis, national medical director for NHS England, is feeling positive.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk says weight-loss drug Wegovy approved in ChinaNovo Nordisk's flagship weight-loss drug Wegovy has been approved for use in China, the Danish pharmaceutical giant said.
Read more »
Weight-loss jabs including Ozempic and Wegovy linked to rare condition that causes blindnessPeople using semaglutide to treat diabetes or lose weight may be at higher risk of developing a condition that causes sudden sight loss, according to a new study.
Read more »
Only 1 in 4 still taking Ozempic, Wegovy for weight loss two years laterThree of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows.
Read more »
Novo Nordisk weight loss drug Wegovy approved in ChinaMove opens market with growing rates of obesity to Danish group’s blockbuster drug
Read more »
Jason Kelce, 36, reveals sentimental reason for weight loss from previous almost 300 lbs. weightThe former Philadelphia Eagles center, Travis Kelce's older brother, retired earlier this year after 13 seasons with the NFL
Read more »
‘Skinny jabs’ like Ozempic and Wegovy could trigger terrifying eye condition and leave you BLIND...Sun Health Explainer: Fat jabs
Read more »